Big Pharma

New insight into neovessel formation shows promise in future treatment of cardiovascular diseases A new study by researchers at the University of Eastern Finland provides novel insight into the previously unknown effects of factors regulating blood vessel formation. In the study, bone morphogenetic factor 6, i.e. BMP6, was shown – for the first time - to regulate blood vessel formation via vascular endothelial growth factor receptor 2 (VEGFR2) and Hippo signalling pathway. The findings can be used in developing treatments for cardiovascular diseases.  Cardiovascular diseases are the leading cause of death in the Western world. In many of these diseases, blood circulation is decreased due to narrowed blood vessels, leading to inadequate tissue perfusion and oxygen deprivation. The formation of new...

Ketamine, a painkiller used by the army, does not impair tolerance for blood loss A low dose of ketamine, administered intravenously, does not alter a healthy human’s tolerance to blood loss. In other words if someone was given ketamine to kill pain associated with a battlefield injury, they would be able to tolerate blood loss just as well as someone who did not received this pain killer. That’s according to new research published today in The Journal of Physiology. Medics in the US Army give ketamine for pain relief associated with a battlefield injury. Such injuries are often accompanied with significant...

Vision-Related Implications of COVID-19 can be Mitigated with Appropriate Care   New York, NY, October , 2020 — About 30 percent of those diagnosed with COVID-19 experience conjunctivitis (an eye infection), and countless others with ocular diseases that require ongoing evaluation and treatment are skipping their checkups out of fears of contracting COVID-19.   Dr. Daniel Laroche, Director of Glaucoma Services and President of Advanced Eyecare of New York, emphasizes that, while the pandemic may have changed the way we visit our doctors, it’s imperative that we stay up-to-date with our vision exams, particularly for those with conditions such as...

Impact of Blockchain in the Health Industry   In the 21st century, we all have witnessed massive changes take place in the world. There has been continuous innovation and up-gradation in technology in all aspects. The more the human civilization stepped up the ladder of innovation, we have made some remarkable changes. Blockchain has become the new sensation in this era. It is the new buzz word in the tech industry. Not only it impacts the mode of transaction, but it impacts the health industry as well.   The impact of the blockchain industry will increase in the upcoming years in...

Is the digital health industry prepared for an unprecedented flu season? During last year’s flu season, only 45% of people in the United States received the flu vaccine. Less than half of the country — despite an estimate by the Centers for Disease Control and Prevention (CDC) that during the 2018–2019 influenza season, more than 35.5 million individuals were infected and more than 16.5 million medical visits, 490,600 hospitalizations, and 34,200 deaths occurred. That’s a concerning prospect, but we’re facing an even more concerning one this year.   The percentage of people receiving the flu vaccine needs to rise for 2020. Here’s...